Understanding how oxidants contribute to nerve injury in diabetes
Dr. Stephanie Eid has served as a diabetes team leader for the NeuroNetwork for Emerging Therapies since January 2019. Her specific interest is understanding the molecular and cellular mechanisms by which oxidative stress injures nerves during diabetes, a condition known as diabetic neuropathy. She is studying free radical production in diabetes, and exploring its role in the onset and progression of nerve damage in diabetes. Dr. Eid uses cellular and animal models of diabetes as well as studies on patients with diabetes. Understanding how free radicals and oxidative stress contribute to nerve injury in diabetes will form the basis for mechanism-based design of new drug therapies.
Credentials
- BS/MS, Physiology, American University of Beirut, 2012
- PhD, Neuroscience, American University of Beirut/Paris Descartes University, Sorbonne Paris Cité, 2017
Honors & Awards
- The Angelika Bierhaus Prize in basic research, Neurodiab (diabetic neuropathy study group of the European Association for the Study of Diabetes)
- National Council for Scientific Research – Lebanon Fellowship
- Training Scholarship, Paris Descartes University
- Travel grant, Peripheral Nerve Society
- Travel grant, National Institute of Diabetes and Digestive and Kidney Diseases
Eid News
Diabetologia: Dr. Stephanie Eid reviews our understanding of microvascular complications in type 2 diabetes
Dr. Stephanie Eid reviews the current state of our understanding of how type 2 diabetes damages the nerve, retina and kidney in patients, and how this damage may be secondary to high blood levels of lipids.